UNSPSC 42142504: Biopsy needles

In this classification, this commodity indicates a product that is a hollow needle commonly used for rapid delivery or evacuation of liquids in a biopsy procedure in a medical setting. US FDA regulates Biopsy needles under 21 CFR 876.1075 and under FDA product code DWO. Most nations, for tariff and trade purposes, schedule these products under HS 901832.

UNSPSC 42142504 Biopsy needles is a Commodity code that covers specimen-collection and diagnostic supplies used across medical examiner offices, occupational health programs, laboratory services, and correctional health clinics. State and local governments procure these items both as discrete components within larger medical-supply master agreements and as part of integrated histology, phlebotomy, and occupational medical services. The code appears in cooperative-purchasing vehicles serving thousands of government entities, in county medical examiner operations, and in departmental occupational health programs. Issuing bodies include state departments of transportation, county purchasing offices on behalf of medical examiner and detention health functions, state cooperative purchasing alliances, and regional cooperative authorities. Recent solicitations show demand driven by regulatory compliance (occupational medicine surveillance, postmortem analysis, correctional health screening) rather than routine clinical restocking.

Recent activity spans multiple states and procurement structures. The Minnesota Multigovernmental Cooperative Purchasing Alliance (MMCAP) RFP posted June 12, 2026 seeks full-line medical-supply distributors serving approximately 8,000 actively purchasing government members with $300 million in collective annual purchasing power, with proposals due July 20, 2026; the scope explicitly includes specimen collection supplies alongside needles, syringes, and related items. NASPO ValuePoint RFP 1433, posted September 25, 2026 with proposals due November 9, 2026, establishes master agreements for medical supplies across multiple states administered by South Dakota. Marion County, Oregon issued ITB SO1814-26 on July 10, 2026 for laboratory testing services and phlebotomy for Adults in Custody, due July 24, 2026, specifying specimen collection supplies and phlebotomist services. The Washington State Department of Transportation, on behalf of Washington State Ferries, posted RFP 20260825 on August 25, 2026 for occupational medical surveillance services across 14 Washington locations with proposals due October 9, 2026, requiring medical examinations for multiple personnel categories. Brevard County Purchasing Services, on behalf of the County Medical Examiner's Office, posted RFQ RFQ72607 on September 21, 2026 seeking histology laboratory services; the due date shown in the source (July 8, 2026) predates the post date and likely reflects a data error, but the solicitation requires specialized staining and analysis capabilities reflecting postmortem diagnostic demand. Cooperative purchasing vehicles and multistate master agreements dominate the recent opportunity set, indicating that vendors pursuing state and local biopsy-needle procurement should prioritize NASPO ValuePoint, MMCAP, and similar cooperative frameworks over single-jurisdiction responses.